0000899243-20-018175.txt : 20200701 0000899243-20-018175.hdr.sgml : 20200701 20200701192823 ACCESSION NUMBER: 0000899243-20-018175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200629 FILED AS OF DATE: 20200701 DATE AS OF CHANGE: 20200701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CRANSTON MARY B CENTRAL INDEX KEY: 0001104268 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 201006604 MAIL ADDRESS: STREET 1: C/O VISA INC. STREET 2: P.O. BOX 8999 CITY: SAN FRANCISCO STATE: CA ZIP: 94128-8999 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia, Inc. CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: MyoKardia Inc DATE OF NAME CHANGE: 20120618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-29 0 0001552451 MyoKardia, Inc. MYOK 0001104268 CRANSTON MARY B C/O MYOKARDIA, INC. 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 1 0 0 0 Common Stock 2020-06-29 4 M 0 371 11.69 A 371 D Common Stock 2020-06-29 4 S 0 371 98.6821 D 0 D Common Stock 2020-06-30 4 M 0 21629 11.69 A 21629 D Common Stock 2020-06-30 4 S 0 300 97.2547 D 21329 D Common Stock 2020-06-30 4 S 0 21329 96.5905 D 0 D Stock Option (Right to Buy) 11.69 2020-06-29 4 M 0 371 0.00 D 2026-04-10 Common Stock 371 21629 D Stock Option (Right to Buy) 11.69 2020-06-30 4 M 0 21629 0.00 D 2026-04-10 Common Stock 21629 0 D Represents the weighted average sale price of the shares sold ranging from $98.50 to $98.725 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the ranges set forth in footnotes 1 through 3. Represents the weighted average sale price of the shares sold ranging from $97.247 to $97.27 per share. Represents the weighted average sale price of the shares sold ranging from $96.24 to $97.236 per share. The shares subject to the option vested in 48 equal monthly installments from April 11, 2016 to April 11, 2020. /s/Cynthia J. Ladd, as Attorney-in-Fact 2020-07-01